CryoLife, a Georgia-based medical device company, develops and manufactures implantable biological devices and surgical adhesives for cardiac and vascular reconstruction.
Artivion, formerly known as CryoLife, is a medical device company focused on developing innovative solutions for cardiac and vascular surgeons. The company specializes in creating implantable biological devices, surgical adhesives, and biomaterials for aortic reconstruction and treatment of aortic diseases. Artivion's mission is to deliver breakthrough technologies that address complex surgical challenges and improve patient outcomes.
The company has made significant strides in advancing aortic technologies, with a particular emphasis on quality and far-reaching impact. Artivion's product portfolio includes the CryoValve SG pulmonary heart valve and other devices for cardiac and vascular applications. Recent clinical data has shown promising results for their AMDS technology, demonstrating a meaningful reduction in all-cause mortality for patients with aortic diseases.
